SILK

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Silk Road Medical Inc

Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke.
CEO
Erica Rogers
Employees
281
Headquarters

1213 Innsbruck Dr
Sunnyvale, California 94089-1317
Phone: 16505669060
silkroadmed.com

News

Silk Road Medical''s Q2 Margins Hit By Manufacturing Expansion Costs
Jul 27, 2022 13:31pm

Silk Road Medical Inc (NASDAQ: SILK ) posted Q2 revenue of $33.2 million , an increase of 25% Y/Y, driven primarily by increased TCAR adoption, beating the consensus of $31.16 million. "We expanded our FDA label and Medicare coverage for the use of TCAR in standard surgical risk patients, formally … Full story available on Benzinga.com


Source:Benzinga
Silk Road Medical PT Raised to $47 at Wolfe Research
Jul 27, 2022 06:31am

https://www.investing.com/news/pro/silk-road-medical-pt-raised-to-47-at-wolfe-research-432SI-2854690


Source:Investing.com
Silk Road Medical, Inc 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:SILK)
Jul 26, 2022 20:40pm

The following slide deck was published by Silk Road Medical, Inc in conjunction with their 2022 Q2 earnings call.


Source:Seeking Alpha
Silk Road Medical Reports Second Quarter 2022 Financial Results
Jul 26, 2022 20:05pm

SUNNYVALE, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2022.


Source:GlobeNewswire
Earnings Preview: Silk Road Medical
Jul 25, 2022 19:04pm

Silk Road Medical (NASDAQ: SILK ) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here''s what investors need to know before the announcement. Analysts estimate that Silk Road Medical will report an earnings per share (EPS) of $-0.46. Silk Road Medical bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on Benzinga.com


Source:Benzinga
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
Jul 22, 2022 17:26pm

Silk Road Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.


Source:Investor''s Business Daily
Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
Jul 19, 2022 17:03pm

We see a lack of forward upside capture in Silk Road Medical (SILK), mitigating its inclusion in long-only equity portfolios. See why we remain neutral on SILK.


Source:Seeking Alpha
Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022
Jul 12, 2022 20:15pm

SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2022 after market close on Tuesday, July 26, 2022. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.


Source:GlobeNewswire
Silk Road Medical falls after Citigroup downgrades to Sell from Neutral
Jul 11, 2022 15:16pm

Citigroup downgraded medical device company Silk Road Medical (SILK) to Sell from Neutral in a research note issued on Monday. The firm has a price target of $33, implying a downside…


Source:Seeking Alpha
Silk Road Medical Inc (NASDAQ: SILK): Is It Stable And Growing?
Jun 25, 2022 15:30pm

Silk Road Medical Inc (NASDAQ:SILK) shares, rose in value on Friday, 06/24/22, with the stock price up by 1.17% to the previous day’s close as strong demand from buyers drove the stock to $39.63. Actively observing the price movement in the last trading, the stock closed the session at $39.17, falling within a range of … Silk Road Medical Inc (NASDAQ: SILK): Is It Stable And Growing? Read More »


Source:Stocks Register